Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Ventyx Biosciences discloses TYK2 ligands

Oct. 19, 2020

ImmunityBio receives FDA clearance for phase I trial of hAd5-COVID-19

Oct. 16, 2020

Phase I/II study of PLX-PAD for GvHD cleared to advance to cohort 2

Oct. 13, 2020

Fluvoxamine reduced the likelihood of hospitalization in patients with mild COVID-19

Oct. 9, 2020

FDA issues complete response letter for remestemcel-L in pediatric steroid-refractory acute GvHD

Oct. 2, 2020

Australian researchers uncover critical aspects of MR1 protein to boost immune system

Sep. 28, 2020

Blueprint reports data from EXPLORER and PATHFINDER trials of Ayvakit in systemic mastocytosis

Sep. 22, 2020

A tense defense

Sep. 22, 2020

Vaxess partners with Medigen Vaccine on combined COVID-19 and influenza vaccine

Sep. 18, 2020

Bristol-Myers Squibb identifies TYK2 inhibitors

Sep. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...